Skip to main content
Premium Trial:

Request an Annual Quote

New Products: BGI Tech's Exome Service

Premium

BGI Tech has launched a human exome sequencing service based on Complete Genomics' sequencing technology that includes in-depth bioinformatics analysis and SNP validation. The service is available for $599 until Dec. 31 and includes 100x average sequencing depth for target regions, SNP analysis, and indel calling and annotation. BGI Tech also has an exome sequencing workflow and pipeline to address cancer study design and challenges.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.